The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder

World Journal of Biological Psychiatry - Tập 14 Số 3 - Trang 154-219 - 2013
Heinz Grunze1,2, Eduard Vieta3, Guy M. Goodwin4, Charles B. Nemeroff5, Gary D. Tollefson6, Hans‐Jürgen Möller1, Siegfried Kasper7
1Ludwig-Maximilians-University, Department of Psychiatry, Munich, Germany
2Newcastle University, Institute of Neuroscience, Newcastle upon Tyne, UK
3Bipolar Disorders Programme, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
4University of Oxford Department of Psychiatry, Warneford Hospital, Oxford, UK
5University of Texas Health Science Center, Department of Psychiatry, San Antonio, TX, USA
6Mood Disorders Research Unit, Aarhus University Hospital, Risskov, Denmark
7Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abou-Auda HS, 2008, Bipolar Disord, 10, 369, 10.1111/j.1399-5618.2007.00549.x

Adams J, 2000, Acta Psychiatr Scand, 101, 119, 10.1034/j.1600-0447.2000.90061.x

Agarkar S, 2011, J Neuropsychiatry Clin Neurosci, 23, 12, 10.1176/jnp.23.2.jnpe12

Ahlfors UG, 1981, Acta Psychiatr Scand, 64, 226, 10.1111/j.1600-0447.1981.tb00778.x

Allen MH, 2006, Am J Psychiatry, 163, 272, 10.1176/appi.ajp.163.2.272

Altamura AC, 2003, J Affect Disord, 76, 267, 10.1016/S0165-0327(02)00075-7

10.1176/appi.ajp.160.7.1252

10.4088/JCP.v67n1009

Altshuler LL, 2009, J Clin Psychiatry, 70, 450, 10.4088/JCP.08m04191

American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders. 4th revised ed

10.1097/01.yic.0000171519.64080.c9

Amsterdam JD, 2010, Am J Psychiatry, 167, 792, 10.1176/appi.ajp.2009.09020284

10.1097/00004714-199812000-00003

Anderson J, 2000, J Rheumatol, 27, 540

10.1016/S0165-0327(01)00377-9

Angst J, 1981, Handbook of Biological Psychiatry, 225

Angst J, 1995, Schweiz Arch Neurol Psychiatr, 146, 17

10.1080/13811110590929488

10.1001/archpsyc.1967.01730200030005

Baastrup PC, 1970, Lancet, 2, 326, 10.1016/S0140-6736(70)92870-9

Baldessarini RJ, 1999, J Clin Psychiatry, 60, 77, 10.4088/JCP.v60n0202

Baldessarini RJ, 1999, Bipolar Disord, 1, 91, 10.1034/j.1399-5618.1999.010206.x

Baldessarini RJ, 1999, Bipolar Disord, 1, 17, 10.1034/j.1399-5618.1999.10106.x

10.1111/j.1399-5618.2006.00344.x

10.1080/15622970802465807

Bauer MS, 2006, J Clin Psychiatry, 67, 48, 10.4088/JCP.v67n0108

10.1111/j.1600-0447.1976.tb00060.x

Becker D, 2002, Eur Psychiatry, 17, 349, 10.1016/S0924-9338(02)00688-0

Belmaker RH, 2010, World J Biol Psychiatry, 11, 76, 10.3109/15622970903414196

Benabarre A, 2009, Actas Esp Psiquiatr, 37, 143

10.1038/ki.2009.433

10.1016/j.biopsych.2008.04.022

Berk M, 2008, J Affect Disord, 106, 153, 10.1016/j.jad.2007.06.011

10.1016/j.jad.2012.01.047

10.1192/bjp.bp.107.037887

Beynon S, 2009, J Psychopharmacol, 23, 574, 10.1177/0269881108093885

Bond DJ, 2008, J Clin Psychiatry, 69, 1589, 10.4088/JCP.v69n1009

10.1016/j.jad.2009.05.014

10.1080/13811110590929541

Bowden CL, 1997, Psychopharmacol Bull, 33, 693

10.1001/archpsyc.57.5.481

10.1001/archpsyc.60.4.392

10.4088/JCP.09m05482yel

Bowden CL, 2012, Acta Psychiatry, 64, 1013

Calabrese JR, 1991, J Clin Psychopharmacol, 11, 396, 10.1097/00004714-199112000-00026

10.4088/JCP.v61n1106

Calabrese J, 2003, J Clin

Calabrese JR, 2004, Biol Psychiatry, 56, 957, 10.1016/j.biopsych.2004.09.022

Calabrese JR, 2005, Am J Psychiatry, 162, 2152, 10.1176/appi.ajp.162.11.2152

Calabrese JR, 2006, Biol Psychiatry, 59, 1061, 10.1016/j.biopsych.2006.02.034

10.1111/j.1399-5618.2011.00974.x

10.1016/S0165-0327(02)00046-0

Carta MG, 2006, Clin Pract Epidemiol Ment Health, 2, 19, 10.1186/1745-0179-2-19

Chengappa KN, 2005, Bipolar Disord, 7, 68, 10.1111/j.1399-5618.2004.00171.x

10.1176/appi.ajp.162.10.1805

Colom F, 2006, J Affect Disord, 93, 13, 10.1016/j.jad.2006.01.032

10.1016/j.jad.2008.03.023

10.4088/JCP.v67n0514

10.1176/ajp.150.5.720

Coxhead N, 1992, Acta Psychiatr Scand, 85, 114, 10.1111/j.1600-0447.1992.tb01453.x

Cundall RL, 1972, Psychol Med, 2, 308, 10.1017/S0033291700042616

Denicoff KD, 1997, Am J Psychiatry, 154, 1456, 10.1176/ajp.154.10.1456

Denicoff KD, 1997, J Clin Psychiatry, 58, 470, 10.4088/JCP.v58n1102

10.1002/da.1078

Diav-Citrin O, 2005, J Clin Psychiatry, 66, 317, 10.4088/JCP.v66n0307

10.1176/appi.ps.55.1.54

Dubovsky SL, 2011, Expert Opin Pharmacother, 12, 817, 10.1517/14656566.2011.563237

Duffy A, 2009, BMC Psychiatry, 9, 4, 10.1186/1471-244X-9-4

Dunner DL, 1998, J Clin Psychiatry, 59, 48

10.1001/archpsyc.1974.01760080077013

El-Mallakh RS, 2008, J Affect Disord, 111, 372, 10.1016/j.jad.2008.03.025

Elphick M, 1985, Br J Psychiatry, 147, 198, 10.1192/bjp.147.2.198

Emrich HM, 1992, Prog Neuropsychopharmacol Biol Psychiatry, 16, 691, 10.1016/0278-5846(92)90025-A

Ernst CL, 2002, J Clin Psychiatry, 63, 42

Esparon J, 1986, Br J Psychiatry, 148, 723, 10.1192/bjp.148.6.723

Fagiolini A, 2003, Am J Psychiatry, 160, 112, 10.1176/appi.ajp.160.1.112

10.1111/j.1399-5618.2005.00234.x

Fieve RR, 1976, Am J Psychiatry, 133, 925, 10.1176/ajp.133.8.925

Findling RL, 2012, J Clin Psychiatry, 73, 57, 10.4088/JCP.11m07104

Fitzgerald BJ, 2002, Pharmacotherapy, 22, 1500, 10.1592/phco.22.16.1500.33697

10.1186/1744-859X-8-16

Fountoulakis KN, 2004, Ann Gen Hosp Psychiatry, 3, 10, 10.1186/1475-2832-3-10

10.1177/0269881112440514

Franchini L, 1999, Eur Arch Psychiatry Clin Neurosci, 249, 227, 10.1007/s004060050091

Frangou S, 2006, Br J Psychiatry, 188, 46, 10.1192/bjp.188.1.46

10.1001/archpsyc.1991.01810330075011

10.1016/j.amjmed.2005.11.003

Frye MA, 2011, New Engl J Med, 364, 51, 10.1056/NEJMcp1000402

Frye MA, 1996, J Clin Psychopharmacol, 16, 87, 10.1097/00004714-199602000-00022

10.4088/JCP.v67n1108

Frye MA, 2009, Am J Psychiatry, 166, 164, 10.1176/appi.ajp.2008.08030322

Garcia-Lopez A, 2001, Actas Esp Psiquiatr, 29, 327

Geddes JR, 2004, Am J Psychiatry, 161, 217, 10.1176/appi.ajp.161.2.217

10.1016/S0140-6736(09)61828-6

Ghaemi SN, 2008, Am J Psychiatry, 165, 300, 10.1176/appi.ajp.2007.07121931

10.1097/00004850-199711000-00006

Ghaemi SN, 2004, Ann Clin Psychiatry, 16, 69, 10.1080/10401230490453103

Ghaemi SN, 2006, Psychiatr Serv, 57, 660, 10.1176/ps.2006.57.5.660

Ghaemi SN, 2008, Acta Psychiatr Scand, 118, 347, 10.1111/j.1600-0447.2008.01257.x

Ghaemi SN, 2010, J Clin Psychiatry, 71, 372, 10.4088/JCP.08m04909gre

10.1176/appi.ajp.2007.07030454

10.1001/archgenpsychiatry.2009.159

Gitlin M, 1999, Drug Saf, 20, 231, 10.2165/00002018-199920030-00004

10.1176/ajp.152.11.1635

Gitlin MJ, 2010, Curr Med Res Opin, 26, 1835, 10.1185/03007995.2010.489830

10.1111/j.1399-5618.2007.00325.x

Goldberg JF, 2008, Biol Psychiatry, 63, 125, 10.1016/j.biopsych.2006.12.031

10.4088/JCP.08m04301

10.4088/JCP.08m04301

Goldsmith DR, 2003, Drugs, 63, 2029, 10.2165/00003495-200363190-00009

Goncalves N, 1985, Nervenarzt, 56, 43

10.1111/j.1399-5618.2006.00368.x

10.1016/j.jad.2010.11.037

Goodwin FK, 2002, J Clin Psychiatry, 63, 5

Goodwin FK, 2007, Manic-depressive illness, 2

10.1001/jama.290.11.1467

Goodwin GM, 1994, Br J Psychiatry, 164, 149, 10.1192/bjp.164.2.149

10.1177/0269881109102919

10.4088/JCP.v65n0321

Goodwin GM, 2008, Eur Neuropsychopharmacol, 18, 787, 10.1016/j.euroneuro.2008.07.005

Grande I, 2012, J Affect Disord, 143, 102, 10.1016/j.jad.2012.05.035

Grande I, 2012, Int J Neuropsychopharmacol, 1

Greil W, 1999, Int Clin Psychopharmacol, 14, 283, 10.1097/00004850-199914050-00003

Greil W, 1999, Int Clin Psychopharmacol, 14, 277, 10.1097/00004850-199914050-00002

Greil W, 1997, Eur Arch Psychiatry Clin Neurosci, 247, 42, 10.1007/BF02916252

Greil W, 1997, J Affect Disord, 43, 151, 10.1016/S0165-0327(96)01427-9

Grof P, 1979, Arch Gen Psychiatry, 36, 891, 10.1001/archpsyc.1979.01780080065015

Grof P, 2010, Neuropsychobiology, 62, 8, 10.1159/000314305

Grof P, 2002, J Clin Psychiatry, 63, 942, 10.4088/JCP.v63n1013

Grunze H, 2002, WPA Series “Evidence Experience in Psychiatry” – Bipolar disorder, 229

Grunze H, 2004, Valproat bei manisch-depressiven (bipolaren) Erkrankungen, 2

Grunze H, 2004, World J Biol Psychiatry, 5, 120, 10.1080/15622970410029924

10.1080/15622970902823202

Grunze H, 2010, World J Biol Psychiatry, 11, 81, 10.3109/15622970903555881

Grunze HC, 2008, CNS Spectr, 13, 790, 10.1017/S1092852900013912

10.3109/09638230903469186

10.1038/sj.npp.1300190

Hakkaart-van Roijen L, 2004, Acta Psychiatr Scand, 110, 383, 10.1111/j.1600-0447.2004.00403.x

Han C, 2007, Prog Neuropsychopharmacol Biol Psychiatry, 31, 1219, 10.1016/j.pnpbp.2007.04.017

Hartong EG, 2003, J Clin Psychiatry, 64, 144, 10.4088/JCP.v64n0206

Harvey PD, 2006, J Clin Psychiatry, 67, 14

Harvey PW, 2008, J Psychopharmacol, 22, 20, 10.1177/0269881107082624

10.1016/S0165-0327(01)00451-7

Hayes SG, 1989, J Clin Psychiatry, 50, 35

10.1176/appi.ajp.163.2.185

10.1001/archgenpsychiatry.2010.199

10.1001/archgenpsychiatry.2011.1456

Hullin RP, 1972, Lancet i, 1044

Hummel B, 2002, Neuropsychobiology, 45, 37, 10.1159/000049260

Jefferson JW, 2010, J Clin Psychiatry, 71, 1153, 10.4088/JCP.09m05917yel

Johannessen SI, 2010, Curr Neuropharmacol, 8, 254, 10.2174/157015910792246254

Johnston AM, 1999, Prevalence and risk factors. Br J Psychiatry, 175, 336, 10.1192/bjp.175.4.336

Johnstone EC, 1990, J Affect Disord, 20, 225, 10.1016/0165-0327(90)90054-C

Jones MW, 1998, Can J Neurol Sci, 25, 13, 10.1017/S0317167100034855

Joyce PR, 1988, Int Clin Psychopharmacol, 3, 123, 10.1097/00004850-198804000-00003

10.1016/S0165-0327(02)00324-5

10.1001/archpsyc.1982.04290090053011

10.1517/14740330802423234

Karayal ON, 2011, J Clin Psychiatry, 72, 367, 10.4088/JCP.10m06281gre

10.1176/appi.ajp.160.4.741

Keck PE, 2005, Int J Psychiaty Clin Practice, 9, 271, 10.1080/13651500500305622

10.4088/JCP.v67n0414

10.1016/j.biopsych.2006.03.056

10.4088/JCP.v68n1003

Kemp DE, 2009, J Clin Psychiatry, 70, 113, 10.4088/JCP.07m04022

Kemp DE, 2012, Eur Neuropsychopharmacol, 22, 123, 10.1016/j.euroneuro.2011.06.005

Kessing LV, 1998, Br J Psychiatry, 172, 23, 10.1192/bjp.172.1.23

Kessing LV, 1998, Psychol Med, 28, 1027, 10.1017/S0033291798006862

Kessing LV, 2011, J Psychopharmacol

10.1192/bjp.bp.110.084822

Ketter TA, 2002, J Clin Psychiatry, 63, 146, 10.4088/JCP.v63n0210

Ketter TA, 2007, J Affect Disord, 100, 45, 10.1016/j.jad.2007.02.006

Kleindienst N, 2007, Int Clin Psychopharmacol, 22, 125, 10.1097/01.yic.0000224788.21406.c8

10.1146/annurev.pharmtox.011008.145557

10.1016/S1043-2760(01)00438-6

Kupka RW, 2003, J Clin Psychiatry, 64, 1483, 10.4088/JCP.v64n1213

10.1176/appi.ajp.162.7.1273

10.1097/YCO.0b013e3281a305ab

Lambert PA, 1984, Anticonvulsants in affective disorders, 33

Lancon C, 1996, Encephale, 22, 468

Lebowitz BK, 2001, Neuropsychiatry Neuropsychol Behav Neurol, 14, 177

Leon AC, 2011, J Clin Psychiatry, 72, 580, 10.4088/JCP.10m06552

10.1176/appi.ajp.163.2.232

10.1136/bmj.332.7555.1444

10.1136/bmj.326.7400.1167

Licht RW, 2012, CNS Neurosci Ther, 18, 219, 10.1111/j.1755-5949.2011.00260.x

Licht RW, 2003, Acta Psychiatr Scand Suppl, 1, 10.1034/j.1600-0447.108.s419.1.x

Licht RW, 2008, Bipolar Disord, 10, 79, 10.1111/j.1399-5618.2008.00499.x

Licht RW, 2010, Bipolar Disord, 12, 483, 10.1111/j.1399-5618.2010.00836.x

10.1001/archpsyc.62.4.361

Loo C, 2011, J Affect Disord, 132, 1, 10.1016/j.jad.2010.08.017

10.1111/j.1399-5618.2010.00835.x

Lopez-Jaramillo C, 2010, J Clin Psychiatry, 71, 1055, 10.4088/JCP.08m04673yel

Lusznat RM, 1988, Br J Psychiatry, 153, 198, 10.1192/bjp.153.2.198

Macfadden W, 2009, Bipolar Disord, 11, 827, 10.1111/j.1399-5618.2009.00761.x

Magalhaes PV, 2011, J Affect Disord, 129, 317, 10.1016/j.jad.2010.08.001

Maier W, 2010, Eur Arch Psychiatry Clin Neurosci, 260, 17, 10.1007/s00406-009-0068-3

Maj M, 2000, Bipolar Disord, 2, 93, 10.1034/j.1399-5618.2000.020202.x

Maj M, 1998, Am J Psychiatry, 155, 30, 10.1176/ajp.155.1.30

Malempati RN, 2008, Int Clin Psychopharmacol, 23, 88, 10.1097/YIC.0b013e3282f2b4c5

Mander AJ, 1988, Lancet, 2, 15, 10.1016/S0140-6736(88)92947-9

10.1016/S0165-0327(98)00110-4

10.1111/j.1399-5618.2011.00898.x

Marneros A, 2001, J Affect Disord, 62, 39, 10.1016/S0165-0327(00)00349-9

10.1111/j.1399-5618.2007.00327.x

Martinez-Aran A, 2008, Bipolar Disord, 10, 566, 10.1111/j.1399-5618.2008.00611.x

McElroy SL, 2008, J Affect Disord, 107, 127, 10.1016/j.jad.2007.08.014

10.4088/JCP.08m04942gre

McIntyre RS, 2010, Clin Ther, 32, 32, 10.1016/j.clinthera.2010.01.022

McIntyre RS, 2009, Bipolar Disord, 11, 815, 10.1111/j.1399-5618.2009.00749.x

McIntyre RS, 2010, J Affect Disord, 126, 358, 10.1016/j.jad.2010.04.005

10.4088/JCP.v66n0406

10.1016/S0140-6736(11)61516-X

10.1056/NEJMoa0803531

Melia PI, 1970, Br J Psychiatry, 116, 621, 10.1192/bjp.116.535.621

Meltzer HY, 2003, J Clin Psychiatry, 64, 1122, 10.4088/JCP.v64n0920

10.1176/appi.ajp.2008.08040488

Minnai GP, 2011, J ECT, 27, 123, 10.1097/YCT.0b013e3181dbf797

Mishory A, 2003, Bipolar Disord, 5, 464, 10.1046/j.1399-5618.2003.00070.x

Möller HJ, 2010, Eur Arch Psychiatry Clin Neurosci, 260, 25, 10.1007/s00406-009-0070-9

10.1192/bjp.134.4.382

10.1136/jnnp.2005.074203

Moskowitz AS, 1991, J Clin Psychopharmacol, 11, 272, 10.1097/00004714-199108000-00020

Müller-Oerlinghausen B, 2006, Lithium in neuropsychiatry: The comprehensive guide, 179

Murru A, 2011, Eur Psychiatry

Muzina DJ, 2008, Int J Clin Pract, 62, 679, 10.1111/j.1742-1241.2008.01735.x

Neels HM, 2004, Clin Chem Lab Med, 42, 1228, 10.1515/CCLM.2004.245

Newcomer JW, 2007, J Clin Psychiatry, 68, 8, 10.4088/JCP.0307e08

Nguyen HT, 2009, Adv Ther, 26, 281, 10.1007/s12325-009-0011-z

Nielsen J, 2012, Bipolar Disord, 14, 863, 10.1111/bdi.12018

Nierenberg AA, 2008, Biol Psychiatry, 64, 455, 10.1016/j.biopsych.2008.04.036

Nierenberg AA, 2009, Clin Trials, 6, 637, 10.1177/1740774509347399

Nolen WA, 2007, Acta Psychiatr Scand, 115, 360, 10.1111/j.1600-0447.2007.00993.x

Nolen WA, 2008, Richtlijn bipolaire stoornissen, 2

10.1007/BF00431111

Oquendo MA, 2011, Am J Psychiatry, 168, 1050, 10.1176/appi.ajp.2011.11010163

Pacchiarotti I, 2011, J Affect Disord, 133, 105, 10.1016/j.jad.2011.03.037

Park MH, 2011, Expert Rev Neurother, 11, 1541, 10.1586/ern.11.151

Parker G, 2006, A proof of concept study. J Affect Disord, 92, 205, 10.1016/j.jad.2006.01.024

Passmore MJ, 2003, Bipolar Disord, 5, 110, 10.1034/j.1399-5618.2003.00026.x

10.1176/appi.ajp.162.10.1957

Perova T, 2010, Int J Neuropsychopharmacol, 13, 693, 10.1017/S1461145709000261

Perugi G, 2002, J Clin Psychopharmacol, 22, 584, 10.1097/00004714-200212000-00008

Petrides G, 2011, Neuropsychobiology, 64, 129, 10.1159/000328943

Placidi GF, 1986, J Clin Psychiatry, 47, 490

Popovic D, 2011, Eur Neuropsychopharmacol

Post RM, 1992, Am J Psychiatry, 149, 1727, 10.1176/ajp.149.12.1727

Post RM, 2010, J Clin Psychiatry, 71, 1176, 10.4088/JCP.08m04811yel

Post RM, 2010, J Clin Psychiatry, 71, 864, 10.4088/JCP.08m04994yel

10.1097/01.jcp.0000169068.34322.70

10.1001/archpsyc.1973.01750330035006

10.1001/archpsyc.1973.04200030104017

Prien RF, 1974, Am J Psychiatry, 131, 198, 10.1176/ajp.131.2.198

Puri BK, 1995, Br J Clin Pract, 49, 333, 10.1111/j.1742-1241.1995.tb10004.x

Puzynski S, 1984, Psychopharmacol Bull, 20, 151

Puzynski S, 1984, J Affect Disord, 6, 115, 10.1016/0165-0327(84)90013-2

Quiroz JA, 2010, Biol Psychiatry, 68, 156, 10.1016/j.biopsych.2010.01.015

Quitkin F, 1978, Am J Psychiatry, 135, 570, 10.1176/ajp.135.5.570

Quitkin FM, 1981, Psychopharmacol Bull, 17, 142

Rabheru K, 1997, Can J Psychiatry, 42, 476, 10.1177/070674379704200503

Raucher-Chene D, 2008, J Neurol Sci, 273, 116, 10.1016/j.jns.2008.05.022

Reinares M, 2009, J Affect Disord, 123, 81, 10.1016/j.jad.2009.09.009

Riedel M, 2010, Expert Opin Drug Saf, 9, 659, 10.1517/14740338.2010.486787

Riemann D, 1993, Neuropsychobiology, 27, 163, 10.1159/000118974

Roy-Byrne PP, 1985, Acta Psychiatr Scand Suppl, 317, 1, 10.1111/j.1600-0447.1985.tb10510.x

10.1016/j.schres.2010.07.012

Runge C, 2004, Nervenarzt, 75, 896, 10.1007/s00115-004-1691-x

Rush AJ, 2005, Biol Psychiatry, 58, 355, 10.1016/j.biopsych.2005.05.024

Rybakowski JK, 2010, Int J Neuropsychopharmacol, 13, 617, 10.1017/S1461145710000404

Rybakowski JK, 2001, Bipolar Disord, 3, 63, 10.1034/j.1399-5618.2001.030203.x

10.1006/bbrc.2000.4169

Sachdev PS, 1986, Am J Psychiatry, 143, 942, 10.1176/ajp.143.7.942

Sachs GS, 2000, Postgrad Med Spec Report, 1

Sachs GS, 2007, New Engl J Med, 356, 1711, 10.1056/NEJMoa064135

Sartorius N, 2007, Int J Neuropsychopharmacol, 10, 1

Schneck CD, 2002, Curr Treat Options Neurol, 4, 477, 10.1007/s11940-002-0015-3

Scott J, 2007, Int J Neuropsychopharmacol, 10, 123, 10.1017/S1461145706006900

Scott J, 2009, J Clin Psychiatry, 70, 378, 10.4088/JCP.08m04333

Seemuller F, 2005, Expert Opin Drug Saf, 4, 849, 10.1517/14740338.4.5.849

10.1097/WNF.0b013e3182055c07

Serretti A, 2003, Am J Pharmacogenomics, 3, 17, 10.2165/00129785-200303010-00004

Severus WE, 2001, Harv Rev Psychiatry, 9, 280, 10.1080/10673220127910

Severus WE, 2009, J Affect Disord, 115, 466, 10.1016/j.jad.2008.10.009

Severus WE, 2010, Eur Psychiatry, 25, 443, 10.1016/j.eurpsy.2009.10.009

Shelton RC, 2006, Expert Rev Neurother, 6, 33, 10.1586/14737175.6.1.33

Shukla S, 1984, Am J Psychiatry, 141, 1604, 10.1176/ajp.141.12.1604

Simon GE, 2006, Am J Psychiatry, 163, 41, 10.1176/appi.ajp.163.1.41

Singh V, 2012, Bipolar Disord, 14, 13

10.1111/j.1399-5618.2007.00490.x

Solomon DA, 1998, J Clin Psychopharmacol, 18, 38, 10.1097/00004714-199802000-00007

Solomon DA, 2010, Arch Gen Psychiatry, 67, 339, 10.1001/archgenpsychiatry.2010.15

Spina E, 1996, An update. Clin Pharmacokinet, 31, 198, 10.2165/00003088-199631030-00004

Staiano AE, 2012, Int J Obes (London), 36, 1450, 10.1038/ijo.2011.268

Stallone F, 1973, Am J Psychiatry, 130, 1006, 10.1176/ajp.130.9.1006

10.1001/archpsyc.56.5.407

Stone M, 2009, Br Med J, 339, 2880, 10.1136/bmj.b2880

Suppes T, 1993, Harv Rev Psychiatry, 1, 131, 10.3109/10673229309017072

Suppes T, 1994, Biol Psychiatry, 36, 338, 10.1016/0006-3223(94)90631-9

Suppes T, 2004, Int Clin Psychopharmacol, 19, 173, 10.1097/00004850-200405000-00010

Suppes T, 2005, J Affect Disord, 89, 69, 10.1016/j.jad.2005.07.011

Suppes T, 2007, Int Clin Psychopharmacol, 22, 376, 10.1097/YIC.0b013e3281c55f63

10.1176/appi.ajp.2008.08020189

Szabo CP, 1993, S Afr Med J, 83, 442

10.1097/JCP.0b013e31823f872f

Thies-Flechtner K, 1996, Pharmacopsychiatry, 29, 103, 10.1055/s-2007-979553

10.1176/appi.ajp.157.2.220

10.1176/appi.ajp.159.6.1011

10.1001/archpsyc.59.1.62

10.1176/appi.ajp.160.7.1263

10.1001/archpsyc.60.11.1079

Tohen M, 2003, Am J Psychiatry, 160, 2099, 10.1176/appi.ajp.160.12.2099

10.1192/bjp.184.4.337

10.1176/appi.ajp.162.7.1281

10.1176/appi.ajp.163.2.247

10.1192/bjp.bp.107.041301

10.1111/j.1399-5618.2009.00726.x

Tohen M, 2009, J Affect Disord, 116, 43, 10.1016/j.jad.2008.11.003

Tredget J, 2010, J Affect Disord, 126, 436, 10.1016/j.jad.2010.04.018

Tural U, 2010, Psychiatry Clin Neurosci, 64, 79, 10.1111/j.1440-1819.2009.02042.x

Ulcickas YM, 2010, Pharmacoepidemiol Drug Saf, 19, 1124, 10.1002/pds.2047

Undurraga J, 2012, J Affect Disord, 139, 89, 10.1016/j.jad.2012.01.027

10.1111/j.1528-1157.1994.tb02930.x

10.4088/JCP.08m04152

van der Loos ML, 2011, Bipolar Disord, 13, 111, 10.1111/j.1399-5618.2011.00887.x

Vencovsky E, 1984, Anticonvulsants in affective disorders, 66

Vernon AC, 2012, Biol Psychiatry, 71, 855, 10.1016/j.biopsych.2011.12.004

10.1016/j.euroneuro.2011.11.011

Vieta E, 2011, New Engl J Med, 364, 1581

10.1111/j.1399-5618.2007.00561.x

10.1034/j.1399-5618.2002.01204.x

Vieta E, 2004, J Clin Psychopharmacol, 24, 374, 10.1097/01.jcp.0000130556.01373.45

Vieta E, 2006, J Clin Psychiatry, 67, 473, 10.4088/JCP.v67n0320

Vieta E, 2008, Int J Neuropsychopharmacol, 11, 445, 10.1017/S1461145708008596

Vieta E, 2008, World J Biol Psychiatry, 9, 219, 10.1080/15622970701530917

10.1016/j.jad.2008.06.001

10.1176/appi.ajp.2008.07101560

10.1016/j.jad.2009.02.028

10.1016/j.jad.2009.02.028

10.1007/s11920-009-0075-0

10.1185/03007991003779380

10.1017/S1461145711000885

Vieta E, 2012, Eur Neuropsychopharmacol, 22, 825, 10.1016/j.euroneuro.2012.03.004

Vieta E, 2012, J Affect Disord, 142, 36, 10.1016/j.jad.2012.04.014

Viguera AC, 2007, J Clin Psychiatry, 68, 29

10.1016/j.eurpsy.2011.06.003

10.1192/bjp.150.2.180

Weisler RH, 2006, CNS Drugs, 20, 219, 10.2165/00023210-200620030-00004

10.4088/JCP.11m06878

10.1111/j.1399-5618.2009.00665.x

Woo YS, 2011, Hum Psychopharmacol, 26, 543, 10.1002/hup.1240

World Health Organization, 1992, Clinical descriptions and diagnostic guidelines

10.1192/bjp.182.2.141

10.1111/j.1399-5618.2009.00672.x

Yildiz A, 2011, Neuropsychopharmacology, 36, 375, 10.1038/npp.2010.192

10.1176/appi.ajp.161.4.608

Yoshimura R, 2006, Pharmacopsychiatry, 39, 233, 10.1055/s-2006-951386

Young AH, 2011, Br J Psychiatry, 198, 336, 10.1192/bjp.bp.110.082875

10.4088/JCP.08m04995gre

10.1016/j.jad.2011.06.016

Young AH, 2012, World J Biol Psychiatry

10.1192/bjp.133.5.429

Zarate CA, 2004, Am J Psychiatry, 161, 169, 10.1176/appi.ajp.161.1.169

Zarate CA, 1995, J Clin Psychiatry, 56, 108

Zhang X, 2011, J Alzheimers Dis, 24, 739, 10.3233/JAD-2011-101875

Zimmerman M, 2012, J Clin Psychiatry, 73, 790, 10.4088/JCP.11m07203

Zis AP, 1980, Psychopharmacol Bull, 16, 47